Accueil>>Signaling Pathways>> GPCR/G protein>> Adrenergic Receptor>>Bambuterol (hydrochloride)

Bambuterol (hydrochloride) (Synonyms: KWD 2183)

Catalog No.GC42896

Bambuterol (chlorhydrate) ((±)-Bambuterol (chlorhydrate); KWD-2183 chlorhydrate) est un agoniste des récepteurs bêta-adrénergiques à longue durée d'action (LABA) utilisé dans le traitement de l'asthme; c'est aussi une prodrogue de la terbutaline.

Products are for research use only. Not for human use. We do not sell to patients.

Bambuterol (hydrochloride) Chemical Structure

Cas No.: 81732-46-9

Taille Prix Stock Qté
100mg
38,00 $US
En stock
500mg
85,00 $US
En stock
1g
133,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Bambuterol hydrochloride ((±)-Bambuterol hydrochloride; KWD-2183 hydrochloride) is a long acting beta-adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a prodrug of terbutaline.

Bambuterol ((±)-Bambuterol hydrochloride; KWD-2183 hydrochloride) is contraindicated in pregnancy and in people with seriously impaired liver function. It can be used by people with renal impairment, but dose adjustments are necessary. The adverse effect profile of bambuterol is similar to that of salbutamol, and may include fatigue, nausea, palpitations, headache, dizziness and tremor.

References:
[1]. Bambuterol, From Wikipedia

Avis

Review for Bambuterol (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Bambuterol (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.